{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T07:38:43Z","timestamp":1762846723057,"version":"build-2065373602"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Most studies in febrile infants evaluated individual laboratory data to predict diagnoses of febrile infants, not taking into consideration the combination of data. In this study we aimed to analyze the diagnostic accuracy \u2013 both individually and in combination \u2013 of C-reactive protein (CRP), procalcitonin (PCT), white blood cell count (WBC), and neutrophil count (ANC), along with clinical findings, in predicting whether a young febrile infant has a viral infection, urinary tract infection (UTI) or serious bacterial infection (SBI). This is a retrospective, observational, single center, cohort study during a period of 7\u00a0years (2018\u20132024). A total of 615 patients were included in the study, of which 352 male (57.3%) with a median age of 51\u00a0days (IQR). For the detection of SBI, AUC values were greater for PCT (OR 1.130; 95% CI: 1.062\u20131.203,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001; AUC 0.75) than for CRP (OR 1.017; 95% CI: 1.008\u20131.026,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001; AUC 0.64). The comparison of ROC curves for CRP and PCT suggested no statistically significant difference between the two markers in detecting viral infections, UTI without bacteremia, UTI with bacteremia and SBI. The AUC values of the markers were always higher if used in combination with urinalysis and clinical findings. In addition, antibiotic sparing procedures were implemented in a third of patients with viral infections and oral shift frequently implemented, without negative outcome.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    : Our findings suggest that single biomarkers are not useful in discriminating viral and bacterial infections, but a combination of CRP (or PCT), urinalysis, and clinical findings, may be more accurate.\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Febrile infants under 90\u00a0days of age are at high risk for serious bacterial infections, often leading to invasive testing and antibiotic treatment. However, single biomarkers like CRP or PCT have limited diagnostic accuracy.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Combining biomarkers with clinical findings and urinalysis improves diagnostic precision, potentially reducing unnecessary treatments and supporting safer, individualized management strategies in this population.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-025-06528-4","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:13:25Z","timestamp":1759990405000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic multiparametric models and antibiotic practices in febrile infants younger than 90\u00a0days"],"prefix":"10.1007","volume":"184","author":[{"given":"Laura","family":"Martino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Camporesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Lazzareschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaspare","family":"Cascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Proli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Bersani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"De Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Zampino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Buonsenso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"6528_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2020-000861","author":"SSY Chang","year":"2021","unstructured":"Chang SSY et al (2021) Predictors of serious bacterial infections using serum biomarkers in an infant population aged 0 to 90 days: a prospective cohort study. BMJ Paediatr Open. https:\/\/doi.org\/10.1136\/bmjpo-2020-000861","journal-title":"BMJ Paediatr Open"},{"issue":"7","key":"6528_CR2","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/INF.0b013e318168d2b4","volume":"27","author":"AG Lacour","year":"2008","unstructured":"Lacour AG, Zamora SA, Gervaix A (2008) A score identifying serious bacterial infections in children with fever without source. Pediatr Infect Dis J 27(7):654\u2013656","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"6528_CR3","doi-asserted-by":"publisher","first-page":"e590","DOI":"10.1542\/peds.2011-1546","volume":"129","author":"TL Greenhow","year":"2012","unstructured":"Greenhow TL, Hung Y-Y, Herz AM (2012) Changing epidemiology of bacteremia in infants aged 1 week to 3 months. Pediatrics 129(3):e590\u2013e596","journal-title":"Pediatrics"},{"key":"6528_CR4","unstructured":"Hui C et al (2012) \u201cEvidence report \/technology assessment diagnosis and management of febrile infants (0\u20133 months)\u201d. [Online]. Available: www.ahrq.gov"},{"key":"6528_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxad085","author":"B Burstein","year":"2024","unstructured":"Burstein B, Lirette MP, Beck C, Chauvin-Kimoff L, Chan K (2024) \u201cManagement of well-appearing febrile young infants aged \u226490 days.\u201d Paediatr Child Health. https:\/\/doi.org\/10.1093\/pch\/pxad085","journal-title":"Paediatr Child Health"},{"key":"6528_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.688272","volume":"9","author":"RG Nijman","year":"2021","unstructured":"Nijman RG, Oostenbrink R, Moll HA, Casals-Pascual C, von Both U, Cunnington A, De T, Eleftheriou I, Emonts M, Fink C, van der Flier M, de Groot R, Kaforou M, Kohlmaier B, Kuijpers TW, Lim E, Maconochie IK, Paulus S, Martinon-Torres F, Pokorn M, Romaine ST, Calle IR, Schlapbach LJ, Smit FJ, Tsolia M, Usuf E, Wright VJ, Yeung S, Zavadska D, Zenz W, Levin M, Herberg JA, Carrol ED (2021) A novel framework for phenotyping children with suspected or confirmed infection for future biomarker studies. Front Pediatr 9:688272. https:\/\/doi.org\/10.3389\/fped.2021.688272","journal-title":"Front Pediatr"},{"issue":"5","key":"6528_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S2352-4642(24)00021-X","volume":"8","author":"H Norman-Bruce","year":"2024","unstructured":"Norman-Bruce H, Umana E, Mills C, Mitchell H, McFetridge L, McCleary D, Waterfield T (2024) Diagnostic test accuracy of procalcitonin and C-reactive protein for predicting invasive and serious bacterial infections in young febrile infants: a systematic review and meta-analysis. Lancet Child Adolesc Health 8(5):358\u2013368. https:\/\/doi.org\/10.1016\/S2352-4642(24)00021-X","journal-title":"Lancet Child Adolesc Health"},{"issue":"11","key":"6528_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.2927","volume":"171","author":"AT Cruz","year":"2017","unstructured":"Cruz AT, Mahajan P, Bonsu BK, Bennett JE, Levine DA, Alpern ER, Nigrovic LE, Atabaki SM, Cohen DM, VanBuren JM, Ramilo O, Kuppermann N (2017) Accuracy of complete blood cell counts to identify febrile infants 60 days or younger with invasive bacterial infections. JAMA Pediatr 171(11):e172927. https:\/\/doi.org\/10.1001\/jamapediatrics.2017.2927","journal-title":"JAMA Pediatr"},{"issue":"2","key":"6528_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1067\/mem.2003.299","volume":"42","author":"BK Bonsu","year":"2003","unstructured":"Bonsu BK, Chb M, Harper MB (2003) Identifying febrile young infants with bacteremia: is the peripheral white blood cell count an accurate screen? Ann Emerg Med 42(2):216\u2013225","journal-title":"Ann Emerg Med"},{"issue":"1","key":"6528_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1651-2227.2006.00033.x","volume":"96","author":"SE Bleeker","year":"2007","unstructured":"Bleeker SE, Derksen-Lubsen G, Grobbee DE, Donders ART, Moons KGM, Moll HA (2007) Validating and updating a prediction rule for serious bacterial infection in patients with fever without source. Acta Paediatr 96(1):100\u2013104","journal-title":"Acta Paediatr"},{"issue":"4","key":"6528_CR11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-069507","volume":"155","author":"A Marom","year":"2025","unstructured":"Marom A, Yannopoulos A, Dionne KA, Burstein B (2025) Procalcitonin and other inflammatory markers in febrile infants aged 60 days or younger. Pediatrics 155(4):e2024069507. https:\/\/doi.org\/10.1542\/peds.2024-069507","journal-title":"Pediatrics"},{"issue":"4","key":"6528_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamapediatrics.2018.5501","volume":"173","author":"N Kuppermann","year":"2019","unstructured":"Kuppermann N, Dayan PS, Levine DA, Vitale M, Tzimenatos L, Tunik MG, Saunders M, Ruddy RM, Roosevelt G, Rogers AJ, Powell EC, Nigrovic LE, Muenzer J, Linakis JG, Grisanti K, Jaffe DM, Jr Hoyle JD, Greenberg R, Gattu R, Cruz AT, Crain EF, Cohen DM, Brayer A, Borgialli D, Bonsu B, Browne L, Blumberg S, Bennett JE, Atabaki SM, Anders J, Alpern ER, Miller B, Casper TC, Dean JM, Ramilo O, Mahajan P (2019) A clinical prediction rule to identify febrile infants 60 days and younger at low risk for serious bacterial infections. JAMA Pediatr 173(4):342\u2013351. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.5501","journal-title":"JAMA Pediatr"},{"key":"6528_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/acem.14921","author":"AT Krack","year":"2024","unstructured":"Krack AT, Eckerle M, Mahajan P, Ramilo O, VanBuren JM, Banks RK, Casper TC, Schnadower D, Kuppermann N, Febrile Infant Working Group of the Pediatric Emergency Care Applied Research Network (PECARN) (2024) Leukopenia, neutropenia, and procalcitonin levels in young febrile infants with invasive bacterial infections. Acad Emerg Med. https:\/\/doi.org\/10.1111\/acem.14921","journal-title":"Acad Emerg Med"},{"issue":"2","key":"6528_CR14","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-4381","volume":"138","author":"B Gomez","year":"2016","unstructured":"Gomez B, Mintegi S, Bressan S, Da Dalt L, Gervaix A, Lacroix L, European Group for Validation of the Step-by-Step Approach (2016) Validation of the \u201cstep-by-step\u201d approach in the management of young febrile infants. Pediatrics 138(2):e20154381. https:\/\/doi.org\/10.1542\/peds.2015-4381","journal-title":"Pediatrics"},{"issue":"11","key":"6528_CR15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S2352-4642(22)00245-0","volume":"6","author":"FM Keij","year":"2022","unstructured":"Keij FM, Kornelisse RF, Hartwig NG, van der Sluijs-Bens J, van Beek RHT, van Driel A, van Rooij LGM, van Dalen-Vink I, Driessen GJA, Kenter S, von Lindern JS, Eijkemans M, Stam-Stigter GM, Qi H, van den Berg MM, Baartmans MGA, van der Meer-Kappelle LH, Meijssen CB, Norbruis OF, Heidema J, van Rossem MC, den Butter PCP, Allegaert K, Reiss IKM, Tramper-Stranders GA (2022) Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial. Lancet Child Adolesc Health 6(11):799\u2013809. https:\/\/doi.org\/10.1016\/S2352-4642(22)00245-0","journal-title":"Lancet Child Adolesc Health"},{"issue":"6","key":"6528_CR16","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1542\/hpeds.2024-007812","volume":"14","author":"D Liang","year":"2024","unstructured":"Liang D (2024) Transitioning to oral antibiotics for young infants: overcoming a historical hesitancy. Hosp Pediatr 14(6):e267\u2013e269. https:\/\/doi.org\/10.1542\/hpeds.2024-007812","journal-title":"Hosp Pediatr"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06528-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06528-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06528-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T07:35:32Z","timestamp":1762846532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06528-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":16,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["6528"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06528-4","relation":{},"ISSN":["1432-1076"],"issn-type":[{"type":"electronic","value":"1432-1076"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was authorized by the ethics committee of the Fondazione Policlinico Universitario A. Gemelli IRCCS of Rome, Italy (Ethic approval ID6199, Protocol n 0035081\/23) and, subsequently, by those of the other participating institutions, and performed\u00a0in accordance with the Declaration of Helsinki. Informed consent was obtained by all patients or legal guardian to use their anonimyzed data for scientific purposes including publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and concent to participation"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"669"}}